(Q81138145)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18431369%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

editorial

0 references

title

Do all drugs and treatments for rheumatoid arthritis have the same efficacy? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18431369%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

Michael H Weisman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18431369%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

22 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18431369%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Rheumatology

6 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18431369%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18431369%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18431369%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

298-299

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18431369%20AND%20SRC:MED&resulttype=core&format=json

Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis

6 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0806

7 January 2021

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0806

7 January 2021

COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0806

7 January 2021

Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0806

7 January 2021

Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0806

7 January 2021

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0806

7 January 2021

Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0806

7 January 2021

Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0806

7 January 2021

Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0806

7 January 2021

The widening mortality gap between rheumatoid arthritis patients and the general population

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0806

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0806

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18431369%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference